146
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Evaluating spin in the abstracts of systematic reviews and meta-analyses on cannabis use disorder

, BSORCID Icon, , EdDORCID Icon, , BSORCID Icon, , BSORCID Icon, , BSORCID Icon, , PhDORCID Icon, , DO, , MLS, , DOORCID Icon & , PhDORCID Icon show all

References

  • Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70.
  • World Drug Report 2019. https://wdr.unodc.org/wdr2019/. Accessed May 28, 2020.
  • Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–2227.
  • Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383–1391.
  • Patel J, Marwaha R. Cannabis use disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
  • Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the national epidemiologic survey on alcohol and related conditions-III. Am J Psychiatry. 2016;173(6):588–599.
  • Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195–212.
  • Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–380.
  • Barry HC, Ebell MH, Shaughnessy AF, Slawson DC, Nietzke F. Family physicians’ use of medical abstracts to guide decision making: style or substance? J Am Board Fam Pract. 2001;14(6):437–442.
  • Islamaj Dogan R, Murray GC, Névéol A, Lu Z. Understanding PubMed user search behavior through log analysis. Database (Oxford). 2009;2009:bap018.
  • Yavchitz A, Ravaud P, Altman DG, et al. A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity. J Clin Epidemiol. 2016;75:56–65.
  • Nakayama T, Hirai N, Yamazaki S, Naito M. Adoption of structured abstracts by general medical journals and format for a structured abstract. J Med Libr Assoc. 2005;93(2):237–242.
  • Boutron I, Altman DG, Hopewell S, Vera-Badillo F, Tannock I, Ravaud P. Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial. J Clin Oncol. 2014;32(36):4120–4126.
  • Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303(20):2058–2064.
  • Yavchitz A, Boutron I, Bafeta A, et al. Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med. 2012;9(9):e1001308.
  • Steegmans PAJ, Di Girolamo N, Meursinge Reynders RA. Spin in the reporting, interpretation, and extrapolation of adverse effects of orthodontic interventions: protocol for a cross-sectional study of systematic reviews. Res Integr Peer Rev. 2019;4(1):1–11.
  • Chiu K, Grundy Q, Bero L. ‘Spin’ in published biomedical literature: a methodological systematic review . PLoS Biol. 2017;15(9):e2002173.
  • Ioannidis JPA, Munafò MR, Fusar-Poli P, Nosek BA, David SP. Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci. 2014;18(5):235–241.
  • McGrath TA, McInnes MDF, van Es N, Leeflang MMG, Korevaar DA, Bossuyt PMM. Overinterpretation of research findings: evidence of “spin” in systematic reviews of diagnostic accuracy studies. Clin Chem. 2017;63(8):1353–1362.
  • Nascimento DP, Gonzalez GZ, Araujo AC, Moseley AM, Maher CG, Costa LOP. Eight in every 10 abstracts of low back pain systematic reviews presented spin and inconsistencies with the full text: an analysis of 66 systematic reviews. J Orthop Sports Phys Ther. 2020;50(1):17–23.
  • Fihn SD. Combating misrepresentation of research findings. JAMA Netw Open. 2019;2(5):e192553.
  • Introduction to Systematic Review and Meta-Analysis. https://www.coursera.org/learn/systematic-review. Accessed June 13, 2020.
  • Hartwell M. AMSTAR 2 training. https://osf.io/wy3cn/. Published online June 4, 2020. Accessed November 8, 2020.
  • Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.
  • Storman M, Storman D, Jasinska KW, Swierz MJ, Bala MM. The quality of systematic reviews/meta‐analyses published in the field of bariatrics: a cross‐sectional systematic survey using AMSTAR 2 and ROBIS. Obesity Reviews. 2020;21(5):e12994.
  • Li Q, Deng K, Jiang X, Tao H, Liu H, Chen J. Methodological quality assessment of systematic review or meta-analysis using AMSTAR-2: the long-term effectiveness or efficacy of opioids for chronic non-cancer pain. Published online August 6, 2019.
  • Zhang H, Han J, Zhu Y-B, et al. Reporting and methodological qualities of published surgical meta-analyses. J Clin Epidemiol. 2016;70:4–16.
  • Goldkuhle M, Narayan VM, Weigl A, Dahm P, Skoetz N. A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer. BMJ Open. 2018;8(3):e020869.
  • Matthias K, Rissling O, Nocon M, et al. Appraisal of the methodological quality of systematic reviews on pharmacological and psychological interventions for major depression in adults using the AMSTAR 2. Published online May 30, 2019;
  • Lorenz RC, Matthias K, Pieper D, et al. A psychometric study found AMSTAR 2 to be a valid and moderately reliable appraisal tool. J Clin Epidemiol. 2019;114:133–140.
  • Ottwell R, Rogers TC, Michael Anderson J, Johnson A, Vassar M. Evaluation of spin in the abstracts of systematic reviews and meta-analyses focused on the treatment of acne vulgaris: cross-sectional analysis. JMIR Dermatol. 2020;3(1):e16978.
  • PRISMA. http://prisma-statement.org/PRISMAStatement/Checklist.aspx. Accessed June 19, 2020.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
  • Kinder NC, Weaver MD, Wayant C, Vassar M. Presence of “‘spin’ in the abstracts and titles of anaesthesiology randomised controlled trials.” Br J Anaesth. 2019;122(1):e13–e14.
  • Khan MS, Lateef N, Siddiqi TJ, et al. Level and prevalence of spin in published cardiovascular randomized clinical trial reports with statistically nonsignificant primary outcomes: a systematic review. JAMA Netw Open. 2019;2(5):e192622.
  • Roberts WB, Cooper CM, Khattab M, et al. Evaluation of “Spin” in the abstracts of randomized controlled trial reports in cardiology. J Am Osteopath Assoc. 2020;120(11):732–739.
  • Austin J, Smith C, Natarajan K, Som M, Wayant C, Vassar M. Evaluation of spin within abstracts in obesity randomized clinical trials: a cross-sectional review. Clin Obes. 2019;9(2):e12292.
  • Ghannad M, Olsen M, Boutron I, Bossuyt PM. A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkers. J Clin Epidemiol. 2019;116:9–17.
  • Patel SV, Zhang L, Elsolh B, Yu D, Chadi SA. Spin in articles about minimally invasive transanal total mesorectal excision: an assessment of the current literature. Colorectal Dis. 2019;21(1):8–14.
  • Wayant C, Margalski D, Vaughn K, Vassar M. Evaluation of spin in oncology clinical trials. Crit Rev Oncol Hematol. 2019;144:102821.
  • Lieb K, von der Osten-Sacken J, Stoffers-Winterling J, Reiss N, Barth J. Conflicts of interest and spin in reviews of psychological therapies: a systematic review. BMJ Open. 2016;6(4):e010606.
  • Shaqman M, Al-Abedalla K, Wagner J, Swede H, Gunsolley JC, Ioannidou E. Reporting quality and spin in abstracts of randomized clinical trials of periodontal therapy and cardiovascular disease outcomes. PLoS One. 2020;15(4):e0230843.
  • Roszhart JI, Kumar SS, Allareddy V, Childs CA, Elangovan S. Spin in abstracts of randomized controlled trials in dentistry: a cross-sectional analysis. J Am Dent Assoc. 2020;151(1):26–32.e3.
  • Hua F, Sun Q, Zhao T, Chen X, He H. Reporting quality of randomised controlled trial abstracts presented at the SLEEP Annual Meetings: a cross-sectional study. BMJ Open. 2019;9(7):e029270.
  • Li G, Abbade LPF, Nwosu I, et al. A scoping review of comparisons between abstracts and full reports in primary biomedical research. BMC Med Res Methodol. 2017;17(1):181.
  • Lazarus C, Haneef R, Ravaud P, Boutron I. Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention. BMC Med Res Methodol. 2015;15:85.
  • Khan R, Naveed S, Mian N, Fida A, Raafey MA, Aedma KK. The therapeutic role of Cannabidiol in mental health: a systematic review. J Cannabis Res. 2020;2(1):2.
  • Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019;6(5):427–436.
  • Sommer IE, van den Brink W. High-potency cannabis and incident psychosis: correcting the causal assumption. Lancet Psychiatry. 2019;6(6):464–465.
  • Hasan A, von Keller R, Friemel CM, et al. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci. 2020;270(4):403–412.
  • Forti MD, Di Forti M, Morgan C, Selten J-P, Lynskey M, Murray RM. High-potency cannabis and incident psychosis: correcting the causal assumption – Authors’ reply. The Lancet Psychiatry. 2019;6(6):466–467.
  • Peterson K, Anderson J, Bourne D. Evidence brief: use of patient reported outcome measures for measurement based care in mental health shared decision-making. In: VA Evidence Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2018.
  • Loflin MJE, Kiluk BD, Huestis MA, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: a review and research agenda. Drug Alcohol Depend. 2020;212:107993.
  • Huestis MA, Smith ML. Cannabinoid markers in biological fluids and tissues: revealing intake. Trends Mol Med. 2018;24(2):156–172.
  • Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Anal Bioanal Chem. 2016;408(23):6461–6471.
  • Beller EM, Glasziou PP, Altman DG, et al. PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med. 2013;10(4):e1001419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.